Single dose of atezolizumab plus chemotherapy in active psoriasis with advanced non-small cell lung cancer

Wong, Pui Yee and How, Soon Hin and Ismail, Irnani and Hassan, Radhiana (2021) Single dose of atezolizumab plus chemotherapy in active psoriasis with advanced non-small cell lung cancer. Journal of Oncology Pharmacy Practice. pp. 1-4. ISSN 1078-1552 E-ISSN 1477-092X

PDF Restricted to Registered users only Download (1MB) | Request a copy

Abstract

Abstract Introduction: Immunotherapy has been recognized as the standard of carein addition to chemotherapy in the treatment of advanced non-small cell lung cancer. Most immunotherapy trials, however, exclude patients with autoimmune disease owing to concerns of disease exacerbation. Case report: We report a case of a patient with advanced non-small cell lung cancer and underlying active psoriasis who experienced a remarkable response, without developing psoriasis flares, following treatment with a single dose of atezolizumab and first-line chemotherapy. Management and outcome: The patient remained asymptomatic 10 months since treatment discontinuation, without disease progression, despite having received only a single dose of atezolizumab and six cycles of chemotherapy. Discussion: Little is known about the optimum duration required to achieve a durable response with immunotherapy. Patients with autoimmune disease are commonly excluded from immunotherapy trials owing to a higher risk of autoimmune disease flares or immune-related adverse events. The remarkable outcome observed in this case offers some insights into the possible durable response with limited doses of immunotherapy and a safer approach for administering immunotherapy in patients with autoimmune disease. Initiating chemotherapy to induce remission in active autoimmune disease prior to administering immunotherapy could potentially be an ideal approach that facilitates the use of immunotherapy in this patient population.

Item Type:	Article (Case Report)
Uncontrolled Keywords:	Single dose, immunotherapy, durable response, psoriasis
Subjects:	R Medicine > RC Internal medicine > RC254 Neoplasms. Tumors. Oncology (including Cancer)
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Medicine Kulliyyah of Medicine > Department of Internal Medicine Kulliyyah of Medicine > Department of Radiology
Depositing User:	Dr Irnani Ismail
Date Deposited:	27 Sep 2021 16:12
Last Modified:	27 Sep 2021 16:12
URI:	http://irep.iium.edu.my/id/eprint/92486

Actions (login required)

View Item